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Introduction
The individual health benefits associated with antiretroviral 
therapy (ART) are well established1,2 and treatment of human 
immunodeficiency virus (HIV) infections is now recom-
mended worldwide.3 Over the past decade, governments 
and donors have invested heavily in control and treatment 
of HIV and acquired immunodeficiency syndrome (AIDS). 
ART programmes have been expanded under the assumption 
that – given sufficient coverage – ART can reduce HIV-related 
mortality and reverse the rise in all-cause mortality that has 
been frequently associated with increasing prevalence of HIV 
infection.4,5
In several studies in sub-Saharan Africa, reductions in 
population-level mortality have followed the introduction 
of ART services.6–12 While encouraging, these studies only 
followed the short-term impact of the initiation of an ART 
programme and none was conducted solely in an urban setting 
where HIV prevalence was high.
The prevalence of HIV among adults living in Zambia was 
estimated to be 12.5% in 2011.13,14 Since 2004, the Zambian 
Ministry of Health has being scaling up a programme for HIV 
care and treatment across the country’s nine provinces. By 
2011, 80% of the Zambians who were eligible for ART – more 
than 400 000 people – were receiving treatment.15 In the capital 
city of Lusaka, which has a population of about 1.7 million,16 
HIV treatment in the public sector is currently available at 19 
primary health centres and a tertiary care hospital. Between 
November 2004 and June 2011 – as public sector ART ser-
vices were scaled up – we implemented a population-based, 
repeated cross-sectional study in Lusaka district. Our primary 
hypothesis was that, as the expanding public ART programme 
covered an ever larger proportion of the population, we would 
observe a reduction in all-cause mortality. We also sought to 
describe the trends in HIV-related knowledge, attitudes and 
practices and the trends in the presence of orphans under the 
age of 16 in the city’s households.
Methods
The implementation of our study, which involved 12 
rounds of household surveys, has already been described 
in detail.17 Briefly, we divided Lusaka district into 24 clinic 
catchment areas, each comprising a varying number of 
standard enumeration areas. For each survey round we se-
lected three enumeration areas within each catchment area 
using probability-proportional-to-size sampling. Within 
each selected enumeration area, interviewers first located 
the approximate centre of the area. Then, working outward 
in a randomly selected direction, they selected households 
at regular intervals – such as every fifth household they 
encountered – until they had selected 50 households. If 
interviewers were unable to contact a respondent in a 
selected household after three attempts – or if consent for 
that household’s participation could not be obtained – they 
selected a neighbouring replacement household. In each of 
the 12 survey rounds, interviewers sampled 3600 households 
over a period of about three weeks.
Objective To follow the trends in all-cause mortality in Lusaka, Zambia, during the scale-up of a national programme of antiretroviral 
therapy (ART).
Methods Between November 2004 and September 2011, we conducted 12 survey rounds as part of a cross-sectional study in Lusaka, 
with independent sampling in each round. In each survey, we asked the heads of 3600 households to state the number of deaths in their 
households in the previous 12 months and the number of orphans aged less than 16 years in their households and investigated the heads’ 
knowledge, attitudes and practices related to human immunodeficiency virus (HIV).
Findings The number of deaths we recorded – per 100 person–years – in each survey ranged from 0.92 (95% confidence interval, CI: 
0.78–1.09) in September 2011, to 1.94 (95% CI: 1.60–2.35) in March 2007. We found that mortality decreased only modestly each year 
(mortality rate ratio: 0.98; 95% CI: 0.95–1.00; P = 0.093). The proportion of households with orphans under the age of 16 years decreased 
from 17% in 2004 to 7% in 2011. The proportions of respondents who had ever been tested for HIV, had a comprehensive knowledge of 
HIV, knew where to obtain free ART and reported that a non-pregnant household member was receiving ART gradually increased.
Conclusion The expansion of ART services in Lusaka was not associated with a reduction in all-cause mortality. Coverage, patient adherence 
and retention may all have to be increased if ART is to have a robust and lasting impact at population level in Lusaka.
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Interviewers asked a member of 
each selected household to identify the 
household heads. If an adult male and 
an adult female were identified as joint 
heads of a selected household, the female 
head was selected for interview. This 
preferential selection of female heads 
of households was to facilitate compari-
son of our data with data collected in 
the Zambia Demographic and Health 
Surveys. The selected head was inter-
viewed in English, Nyanja or Bemba. 
The interviewer described the objectives 
of the survey to the head and the head 
was asked for their written informed 
consent. Once consent had been given, 
the interviewer used a standardized 
questionnaire to collect detailed demo-
graphic and medical information about 
all members of the household – includ-
ing the timing of any deaths that had 
occurred among household members 
within the previous 12 months. Inter-
viewees were asked to state how many 
orphans under the age of 16 years were 
living in their households. They were 
also asked about their knowledge, at-
titudes and practices relating to HIV. As 
in the 2007 Zambia Demographic and 
Health Survey,13 interviewees were con-
sidered to have comprehensive knowl-
edge of HIV if they correctly answered 
five questions about HIV transmission 
risk and so indicated that they knew 
that: HIV cannot be transmitted through 
mosquitoes, HIV cannot be transmitted 
by witchcraft, HIV transmission risk can 
be reduced through condom use, HIV 
transmission can be reduced by having 
one HIV-negative sex partner, and a 
healthy-looking person can have HIV.
Interviewees were asked if they 
had ever been tested for HIV and 
whether any non-pregnant members 
of their households were taking ART. 
The Institutional Review Board of the 
University of Zambia, the University of 
North Carolina at Chapel Hill and the 
University of Alabama at Birmingham 
approved the study protocol.
When planning our analysis, we 
assumed that most inhabitants of a 
specific catchment area would seek 
medical care at their local community 
clinic and that study households would 
only have access to ART when ART be-
came available at that clinic. Our initial 
aim was therefore to compare trends in 
all-cause mortality at community level 
and to determine whether mortality 
trends remained the same before and 
after ART became available at the local 
clinic. However, a substantial proportion 
of interviewees in the first survey round 
reported that they had received medical 
care at clinics that were located outside 
their own communities.17 We therefore 
decided to focus on district-wide trends. 
As accurate cause-of-death information 
could not be collected from our inter-
viewees, we studied all-cause mortality 
– rather than HIV-related mortality – as 
our primary outcome measure. To relate 
such mortality to the scale-up of the 
ART programme, we report the number 
of people actively enrolled in the ART 
programme in Lusaka district at the 
time of each survey round, as well as the 
cumulative enrolment.18,19
We tabulated the demographic 
characteristics of the study households 
and interviewees. For each survey 
round, we calculated rates of all-cause 
mortality as the numbers of deaths per 
100 person–years – using the 12 months 
before the interview as the reference 
period. In these calculations, for each 
household member who had died in the 
12 months before the interview and for 
each member who was reported to be 
less than 12 months of age at the time 
of the interview, we used the number of 
months that that member had been alive 
in the previous 12 months and 6 months 
as survival times, respectively.
To determine trends in mortality, 
we used a Poisson regression to esti-
mate the mortality rate ratio – i.e. an 
estimate of the relative annual change 
in mortality – for the period 2004–2011. 
Next, we investigated this ratio for trend 
heterogeneity by sex and age group. The 
age groups we used – under 5, 5–14, 
15–49 and over 50 years – were selected 
to facilitate comparison of our mortality 
data with those collected in Zambian 
Demographic and Health Surveys. We 
also calculated age-standardized mortal-
ity rates, using the INDEPTH Network’s 
population structure for sub-Saharan 
Africa for reference.20
In secondary analyses, we described 
trends in the respondents’ HIV-related 
knowledge, attitudes and practices. 
For each question on such knowledge, 
attitudes and practices, we calculated 
the proportion in each survey round 
of each possible response – i.e. yes, no 
or do not know. We then calculated 
the proportion of comprehensive HIV 
knowledge among the interviewees in 
each survey round. We also described 
trends in the proportions of households 
that included orphans and households 
with a non-pregnant member taking 
ART. We analysed prevalence trends for 
each question using separate generalized 
linear regression models that provided 
estimates of the mean yearly change 
between 2004 and 2011.
The values we report have been ad-
justed for the complex sampling design. We 
calculated standard errors and correspond-
ing 95% confidence intervals (CI) using 
Taylor series linearization.21 Data were 
analysed using Stata 11.2 (StataCorp LP, 
College Station, United States of America).
Results
Of the 43 200 households included in 
our analysis, 3800 (9%) were replace-
ment households. Of the replacement 
households, 2650 (70%) were selected 
because a household head could not 
be contacted and 1088 (29%) because a 
household head declined to participate. 
Interviewees in the 43 200 households 
provided information on 207 798 house-
hold members. Table 1 contains details 
of the timing of the surveys, along with 
contextual information about the num-
ber of clinics providing ART and the 
number of patients receiving ART at the 
time of each survey.
We only observed minor between-
survey differences in the respondents’ 
sex, marital status and – for female 
interviewees – parity. Food security and 
employment increased over the study 
period whereas immigration and denial 
of medical care – because of the patients’ 
inability to pay for care – decreased 
(Table 2). The overall mean age of the 
respondents were 33.2 years (range 
between surveys: 32.2–34.3), they had 
attained education for 8.6 years (range 
between surveys: 8.0–9.5) and had an 
average of three living children (range 
between surveys: 2.9–3.2).
Across all survey rounds, household 
members contributed 204 263 person–
years of survival and 2537 deaths. All-
cause mortality was found to decrease 
modestly over time (mortality rate 
ratio: 0.98; 95% CI: 0.95–1.00; P = 0.093; 
Fig. 1) and a similarly small decrease 
was seen after the age-standardization 
of the data (mortality rate ratio: 0.98; 
95% CI: 0.95–1.00; P = 0.083). Although 
there was clustering of mortality by 
enumeration area, the effective sample 
size for the analysis of mortality trend 
remained extremely large.
As there was no evidence of mor-
tality trend heterogeneity by age group 
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(P = 0.31) or sex (P = 0.50), we calculated 
stratum-specific mortality rates across 
the study period (Table 3). Household 
members between 15 and 49 years of 
age comprised 56% of the sample, and 
experienced a mean mortality of 1.33 
(95% CI: 1.23–1.44) deaths per 100-per-
son years. The corresponding mortality 
rate for the 15% of household members 
who were under 5 years of age was 2.14 
(95% CI: 1.85–2.47) deaths per 100 
person–years. Females comprised over 
half (53%) of the household members 
investigated. Female mortality was lower 
than male: 1.23 (95% CI: 1.14–1.33) 
versus 1.50 (95% CI: 1.39–1.63) deaths 
per 100 person–years.
Over the first seven surveys, inter-
viewees were increasingly likely to know 
where to get free ART. The proportion 
of interviewees who reportedly knew 
where to obtain such free therapy had 
approached 100% by the eighth survey 
and remained very high for the remain-
der of the study period. Across the whole 
study period, interviewees were increas-
ingly likely to report that a non-pregnant 
household member was taking ART; to 
report that they had been tested for HIV; 
to have comprehensive HIV knowledge; 
or to know someone with HIV or some-
one who had died of AIDS. Conversely, 
the proportions of interviewees who re-
portedly believed that HIV/AIDS was “a 
punishment from God for promiscuity” 
and who reported the presence in their 
household of at least one orphan aged 
less than 16 years decreased during the 
study (Fig. 2; P < 0.001 for the trend in 
each measure).
Discussion
Between 2004 and 2011, we documented 
positive trends in HIV-related knowl-
edge, attitudes and practices across 
Lusaka district. These results align 
with the corresponding steady increase 
in individuals enrolled into HIV care 
and actively receiving ART. Although 
our study was timed to coincide with 
the roll-out of one of the largest urban 
ART programmes in Africa,18,22 these 
encouraging trends did not correlate 
with a substantial decline in all-cause 
mortality in our study area. We observed 
measurable increases in employment, 
food security, knowledge about HIV and 
health-care access and decreases in the 
proportion of households with orphan 
members. Taken together, these trends 
indicate an increase in the general well-
being of the study population.
Our failure to observe a substantial 
reduction in mortality contrasts with the 
results of several studies conducted else-
where in Africa. In rural South Africa, 
for example, researchers investigated the 
effects of an ART programme’s expan-
sion over a 3-year period and observed 
reductions in mortality of more than 
20% among adults and about 49% 
among young children.6,7 Similar reduc-
tions in adult mortality were observed 
in rural Malawi, in the 4 years after the 
expansion of an ART programme.8,9 In 
urban Ethiopia, Reniers et al. used data 
from burial site registries and reported 
reductions in adult mortality of more 
than 20% in the 3 years after ART had 
been introduced.10 Burial site surveil-
lance was also used in Malawi, which 
showed a 37% reduction in all-cause 
mortality in the 5 years after ART 
scale-up.11 Finally, investigation of sib-
ling survival data from Demographic 
Table 1. Survey schedule and antiretroviral therapy scale-up, Lusaka district, Zambia, 
2004–2011
Survey 
round
Date No. of public 
clinics 
dispensing 
ARTa
% of district’s house-
holds in catchment 
areas of ART-dispensing 
clinics
No. of people enrolled 
in ART
Cumulative At time of 
surveyb
1 Nov 2004 9 47.9 5 478 5 017
2 Jun 2005 11 60.2 16 544 13 724
3 Nov 2005 11 60.2 24 256 18 739
4 Apr 2006 13 72.5 31 785 22 996
5 Mar 2007 16 82.7 50 921 31 967
6 Aug 2007 16 82.7 59 851 35 350
7 Nov 2007 16 82.7 65 669 38 012
8 Feb 2008 16 82.7 70 910 40 091
9 Sep 2010 19 88.0 131 572 63 358
10 Feb 2011 19 88.0 141 910 66 508
11 Jun 2011 19 88.0 149 342 67 693
12 Sep 2011 19 88.0 154 748 68 018
ART: antiretroviral therapy.
a  Throughout the study period there were 24 public clinics in Lusaka district.
b  Actively enrolled in the ART programme in Lusaka.
Table 2. Characteristics of household respondents, Lusaka district, Zambia, 2004–2011
Characteristic Overalla Minimuma,b Maximuma,b
Proportion of all respondents 
(n = 43 200) 
Female 87.9 82.0 (11) 94.8 (7)
Married or living with partner 76.3 74.0 (11) 81.8 (7)
Giving birth in previous 12 months or partner 
of woman who had given birth in previous 
12 months
13.6 11.3 (10) 16.2 (7)
Always or usually with enough food in the 
household
52.3 40.9 (1) 61.5 (10)
Denied medical care in previous 12 months 
because of inability to pay
8.8 4.4 (12) 15.0 (1)
In household that had moved to its present 
location in previous months
11.1 7.5 (7) 19.4 (1)
Attending local public clinic for health care 69.5 59.2 (11) 76.7 (7)
Proportion of male respondents 
(n = 6059) with paid employment
80.4 74.8 (2) 86.2 (10)
Proportion of female respondents 
(n = 37 141) with paid employment
40.0 32.2 (2) 45.0 (9)
a  The proportions are adjusted for the complex sampling design.
b  As recorded in any of the 12 survey rounds. The survey round in which each value was recorded is 
indicated in parentheses.
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and Health Surveys conducted in 27 
African countries, including nine in 
which an HIV treatment programme 
funded by the United States President’s 
Emergency Plan for AIDS Relief was 
operating, found that the odds of death 
from any cause were 16% lower in these 
nine countries than in the 18 other 
countries.12
Our results also appear inconsistent 
with country-wide data from the World 
Bank and the Joint United Nations 
Programme on HIV and AIDS, which 
indicate that, in Zambia, there have 
been large declines in all-cause mortality 
since 200123 and in HIV-related mortal-
ity since 2003.14
Mathematical models have dem-
onstrated that low or delayed ART up-
take will attenuate reductions in AIDS 
mortality24–27 and this may be applicable 
in Lusaka. However, there are several 
other possible reasons why we failed to 
observe a more substantial reduction 
in all-cause mortality. First, it is pos-
sible that increases in non-HIV-related 
mortality offset the expected declines 
in HIV-related mortality. We believe 
this to be unlikely, however, given the 
apparent improvements in interviewees’ 
socioeconomic status – e.g. in terms of 
employment and food security – and in 
their access to health care. Further, in 
Zambia the risk of death attributable to 
HIV is known to be extremely high.28
Second, our survey began shortly 
after a rapid scale-up began and without 
an opportunity to measure the mortal-
ity rate experienced immediately before 
the introduction of free ART services. 
The introduction of free ART may have 
rapidly led to substantial reductions in 
HIV-related mortality that we simply 
missed because they occurred before 
our first survey.
Third, the threshold of ART cov-
erage necessary to produce major 
community-wide reductions in all-cause 
mortality may not have been reached 
yet. Early screening and entry into care 
are needed to ensure optimal survival 
for HIV-infected individuals. It was only 
early in 2010 that the Zambian ART 
programme adopted more inclusive 
eligibility criteria for ART, including a 
higher CD4+ lymphocyte threshold of 
350 cells per mm3. In addition, greater 
programmatic focus is needed in the 
areas of patient adherence and reten-
tion. Attrition is high in the Lusaka 
ART programme,18,29 as in other ART 
programmes in sub-Saharan Africa.30–32 
As mathematical models show, when 
many patients are lost to follow-up – 
and, therefore, discontinue therapy 
prematurely – the public health benefits 
of ART programme expansion are sub-
stantially reduced.
One encouraging result from our 
study was that the proportion of study 
households that held young orphans 
decreased from 17% in November 2004 
to 7% in September 2011. This apparent 
decline in orphanhood is supported 
by the figures reported in Zambia’s 
Demographic and Health Surveys for 
2001–2002 and 2007.13,33 Orphanhood 
has been shown to be associated with 
adult AIDS mortality.34,35
We also observed encouraging 
trends in HIV-related knowledge, at-
titudes and practices. This observation 
demonstrates the successful penetration 
of health communication messages 
about HIV among the residents of Lusa-
ka. As comprehensive knowledge about 
HIV and of the location of ART services 
approaches universality among the adult 
residents of Lusaka, those residents are, 
presumably, increasingly prepared to 
access ART themselves – if needed – or 
to facilitate the entry of other residents 
into HIV care. The stigma associated 
with HIV appears to be on the wane in 
Lusaka. The proportion of interviewees 
who reported that a non-pregnant mem-
ber of their household was receiving 
ART was only 0.8% in November 2004 
but had risen more than 9-fold, to 7.4%, 
by September 2010.
Fig. 1. Observed and fitted all-cause mortality rates, Lusaka district, Zambia,  
2004–2011
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Table 3. Mortality rates for household members by age group and sex, Lusaka district, 
Zambia, 2004–2011
Characteristic Proportion 
of household 
members (%)
Mortality rate
Deaths/100 person–years 95% CI
Age (years)
< 5 14.7 2.14 1.85–2.47
5–14 24.9 0.42 0.36–0.50
15–49 55.6 1.33 1.23–1.44
≥ 50 4.8 4.44 3.93–5.02
Sex
Male 47.4 1.50 1.39–1.63
Female 52.6 1.23 1.14–1.33
CI: confidence interval.
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The strengths of our study include 
the use of a standardized questionnaire, 
the large sample size and a study period 
that extended beyond the first few years 
after ART scale-up. Our study also had 
some important limitations. First, the 
study relied on data reported by self-
identified heads of households and both 
the reporting and self-identification 
may be prone to bias. Any such bias is, 
however, likely to have been similar in 
each survey round and, reassuringly, the 
mean adult mortality that we recorded 
per 1000 person–years – 13.3 deaths – 
is similar to the corresponding values 
recorded in Zambia’s Demographic and 
Health Surveys for 2001–2002 and 2007: 
14.1 and 12.5 deaths, respectively. Sec-
ond, we made no attempt to investigate 
those members of the study households 
who died more than 12 months before 
the interviews or those who left study 
households – and, possibly, died – in 
the 12 months before the interviews. 
HIV-related immigration into a com-
munity and HIV-related emigration 
out of a community – as described in 
South Africa36 – can create unquantifi-
able bias in the estimation of mortality. 
Third, although HIV-related mortality 
would have been a more useful primary 
outcome in our study, we were unable to 
collect information regarding the cause 
or circumstances surrounding each 
death of interest. Fourth, although only 
9% of the heads of households included 
in the initial selections of households 
for each survey round refused to par-
ticipate in the study, such a level of 
non-participation could have been suf-
ficient to alter our main findings – if 
the non-participating households had 
been systematically different from the 
participating households in terms of 
our primary and secondary outcomes. 
Finally, our sampling frame was based 
on the most recent and available census 
data for Lusaka, which were collected 
in 2000. These data do not necessar-
ily reflect a population that has been 
highly dynamic and growing since the 
year 2000.
In conclusion, despite encourag-
ing increases in comprehensive HIV 
knowledge and improved HIV-related 
attitudes and practices, the expansion 
of ART services in Lusaka between 2004 
and 2011 coincided with only a modest 
reduction in all-cause mortality. While 
this finding was unexpected, it empha-
sizes several critical factors for improv-
ing the population-level impact of ART. 
Further expansion of coverage with ART 
services requires close monitoring and 
investment, particularly for patients 
who qualify for HIV treatment but have 
not yet become ill. Greater coverage 
needs to be accompanied by a more 
systematic application of effective mea-
sures to increase patient adherence and 
retention. Monitoring population-level 
outcomes – using resource-appropriate 
methods such as the one described here 
– should be implemented, to provide 
ongoing feedback on programme per-
formance. Finally, investments in ART 
programmes – and, more broadly, in 
health-systems – must continue. In set-
tings such as Lusaka, which have clearly 
benefited from successful education and 
outreach programmes, a realignment of 
the ART programme’s priorities may be 
needed to ensure maximal public health 
benefit. ■
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Fig. 2. Human immunodeficiency virus-related knowledge and attitudes, as reported by 
household heads, Lusaka district, Zambia, 2004–2011
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صخلم
 :ةيرقهقلا تاسويرفلا تاداضمب جلاعلا جمارب دحأ مجح ةدايز ءانثأ بابسلأا عيجم نع ةجمانلا تايفولا في تاهاتجلاا
ايبمازب ،اكاسول في تاعاطقلا ةددعتم ةسارد
 بابسلأا  عيجم  نع  ةجمانلا  تايفولا  في  تاهاتجلاا  عبتت  ضرغلا
 جلاعلل  ينطولا  جمانبرلا  مجح  ةدايز  ءانثأ  ايبمازب  ،اكاسول  في
.)ART( ةيرقهقلا تاسويرفلا تاداضمب
 برمتبس/لوليأو  2004  برمفون/نياثلا  نيشرت  ينب  انمق  ةقيرطلا
 تاعاطقلا ةددعتم ةسارد نم ءزجك حسم ةلوج 12 ءارجإب 2011
 انبلطو  .ةلوج  لك  في  ةلقتسم  تانيع  ذخأ  مت  ثيح  ،اكاسول  في
 مهسرأ في تايفولا ددع نايب ةسرأ 3600  بابرأ نم حيم لك في
 ةنس 16 نم لقلأا ىماتيلا ددعو ةيضالما ًارهش شرع ينثلاا للاخ
 تاذ متهاسراممو متهاهاتجاو سرلأا بابرأ ةفرعم انيرتحو مهسرأ في
.)HIV( يشربلا يعانلما زوعلا سويرفب ةلصلا
 100  لكل  -  اهليجستب  انمق  يتلا  تايفولا  ددع  حوارت  جئاتنلا
 ،% 95  ةقثلا  لصاف(  0.92  نم  حسم لك في - ةنسلا  في صخش
 1.94 لىإ 2011 برمتبس/لوليأ في )1.09 - 0.78 :ةقثلا لصاف
 سرام/راذآ في )2.35 - 1.60 :ةقثلا لصاف ،% 95 ةقثلا لصاف(
 لدعم  في  طقف  عضاوتم  ضافخنا  دوجو  لىإ  انلصوتو  .2007
 ،% 95 ةقثلا لصاف ؛0.98 :تايفولا لدعم ةبسن( ةنس لك تايفولا
 تضفخناو .)0.093  = لماتحلاا ،1.00  - 0.95  :ةقثلا  لصاف
 ماع في % 17  نم ةنس 16  نس نود ًاماتيأ  مضت يتلا  سرلأا ةبسن
 ينبيجلما  بسن  ًاييجردت  تدادزاو  .2011  ماع  في  % 7  لىإ  2004
 تناكو  يشربلا  يعانلما  زوعلا  سويرف  رابتخلا  اوعضخ  نيذلا
 نكامأب ةفرعمو يشربلا يعانلما زوعلا سويرفب ةلماش ةفرعم ميهدل
 ةيرقهقلا  تاسويرفلا  تاداضمب  نياجلما  جلاعلا  لىع  لوصلحا
 لماولحا يرغ ءاسنلا نم ةسرلأا دارفأ دحأ يقلت نع غلابلإاب اوماقو
.ةيرقهقلا تاسويرفلا تاداضمب جلاعلا
 تاسويرفلا تاداضمب جلاعلا تامدخ عسوت طبتري لم جاتنتسلاا
 عيجم  نع  ةجمانلا  تايفولا  في  ضافخناب  اكاسول  في  ةيرقهقلا
 مهيلع ءاقبلإاو ضىرلما لاثتماو ةيطغتلا ةدايز ينعتي دقو .بابسلأا
 تاداضمب جلاعلل رمتسمو يوق رثأ قيقتح في ةبغر كانه تناك اذإ
.اكاسول في ناكسلا ديعص لىع ةيرقهقلا تاسويرفلا
摘要
扩大抗逆转录病毒治疗项目过程中的全因死亡率趋势：赞比亚卢萨卡横断面研究
目的 跟踪在扩大抗逆转录病毒治疗国家计划（ART）
中赞比亚卢萨卡的全因死亡率的趋势。
方法 在 2004 年 11 月至 2011 年 9 月之间，作为卢萨卡
横断面研究的组成部分，我们进行了 12 轮的调查，每
一轮均独立抽样。我们在每次调查中询问了 3600 户家
庭负责人其家庭在最近 12 个月中的死亡人数、家庭中
16 岁以下孤儿人数并调查负责人艾滋病（HIV）的相
关知识、态度和实践。
结果 我们在每个调查中记录的死亡数（每 100 人年）
在 2011 年 9 月的 0.92（95% 置信区间，CI ：0.78-1.09）
到 2007 年 3 月 的 1.94（95% CI ：1.60-2.35） 的 范 围。
我们发现每年死亡率仅有略微降低（死亡率比 ：0.98 ；
95% CI ：0.95-1.00 ；P = 0.093）。有 16 岁以下孤儿的家
庭比例从 2004 年的 17% 下降到 2011 年的 7%。受访者
曾经进行过艾滋病毒检测、具有艾滋病的综合知识、
知道在何处接受免费 ART 治疗并报告非妊娠家庭成员
正在接受 ART 治疗的比例逐渐增加。
结论 卢萨卡 ART 服务扩张与全因死亡率降低无关联。
如果要使 ART 治疗对卢萨卡人口水平保持强大持久的
影响，可能必须提高覆盖率、病人依循性和保持情况。
Résumé
Tendances dans la mortalité toutes causes confondues au cours du développement d’un programme de traitement 
antirétroviral: une étude transversale à Lusaka, en Zambie
Objectif Suivre les tendances dans la mortalité toutes causes 
confondues à Lusaka, en Zambie, au cours du développement du 
programme national de traitement antirétroviral (TAR).
Méthodes Entre novembre 2004 et septembre 2011, nous avons mené 
12 cycles d’études dans le cadre d’une étude transversale à Lusaka, 
avec un échantillonnage indépendant à chaque cycle. Dans chaque 
étude, nous avons demandé aux chefs de famille de 3600 ménages 
de déclarer le nombre de décès qui avaient eu lieu dans leur famille au 
cours des 12 derniers mois et le nombre d’orphelins âgés de moins de 
16 ans dans leur famille, et nous avons examiné les connaissances, les 
attitudes et les pratiques liées au virus de l’immunodéficience humaine 
(VIH) des chefs de famille.
Résultats Le nombre de décès que nous avons enregistrés – pour 
100 personnes par an – dans chaque étude est compris entre 0,92 
(intervalle de confiance de 95%, IC: 0,78–1,09) en septembre 2011 et 
1,94 (IC de 95%: 1,60–2,35) en mars 2007. Nous avons constaté que la 
mortalité ne diminuait que modestement chaque année (rapport du 
taux de mortalité: 0,98; IC de 95%: 0,95–1,00; P = 0,093). Le pourcentage 
des ménages avec des orphelins de moins de 16 ans a diminué de 17% 
en 2004 à 7% en 2011. Le pourcentage des répondants qui avaient déjà 
été dépistés pour le VIH, qui avaient une connaissance approfondie du 
VIH, qui savaient où obtenir un TAR gratuit et qui avaient déclaré qu’une 
femme non enceinte du ménage bénéficiait d’un TAR, a progressivement 
augmenté.
Conclusion Le développement des services de TAR à Lusaka n’était pas 
associé à une réduction de la mortalité toutes causes confondues. La 
couverture, l’adhésion des patients et la rétention pourraient être toutes 
améliorées si le TAR devait avoir un impact fort et durable au niveau de 
la population à Lusaka.
http://www.elle.be/fr/50810-
swissball-au-bureau-sport-
effort.html
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Резюме
Тенденции общей смертности при расширении масштабов программы антиретровирусной терапии: 
перекрестное исследование в Лусаке, Замбия
Цель Проследить тенденции общей смертности в Лусаке, 
Замбия, при расширении масштабов национальной программы 
антиретровирусной терапии (АРТ).
Методы В период с ноября 2004 года по сентябрь 2011 года 
были проведены 12 раундов опросов в рамках перекрестного 
исследования в Лусаке с независимыми выборками в каждом 
раунде. В ходе каждого опроса от глав 3600 домохозяйств 
требовалось сообщить число смертей в течение предыдущих 
12 месяцев и число сирот в возрасте до 16 лет в своих 
домохозяйствах, а также было проведено исследование знаний, 
отношения и практик глав домохозяйств, связанных с вирусом 
иммунодефицита человека (ВИЧ).
Результаты  Число зарегистрированных смертей на 
100 человеко-лет в каждом опросе варьировалось от 0,92 (95%-
й доверительный интервал, ДИ: 0,78–1,09) в сентябре 2011 года 
до 1,94 (95% ДИ: 1,60–2,35) в марте 2007 года. Было обнаружено, 
что смертность снижалась каждый год лишь незначительно 
(коэффициент смертности: 0,98; 95% ДИ: 0,95–1,00; P = 0,093). 
Доля домохозяйств с сиротами в возрасте до 16 лет снизилась 
с 17% в 2004 году до 7% в 2011 году. Постепенно увеличивалась 
доля респондентов, которые когда-либо проходили тест на 
ВИЧ, обладали всесторонними знаниями о ВИЧ, знали, где 
получить бесплатную АРТ, и сообщили, что небеременные члены 
домохозяйств получали АРТ.
Вывод Расширение услуг по АРТ в Лусаке не было связано со 
снижением общей смертности. Такие показатели, как охват, 
соблюдение пациентами указаний и уровень удержания 
пациентов, могут увеличиться, если АРТ окажет устойчивое и 
продолжительное воздействие на уровень популяции в Лусаке.
Resumen
Las tendencias en la mortalidad general durante la ampliación de un programa de terapia antirretroviral: un estudio 
transversal en Lusaka (Zambia)
Objetivo Seguir las tendencias de la mortalidad general en Lusaka 
(Zambia) durante la ampliación de un programa nacional de una terapia 
antirretroviral (TARV).
Métodos Como parte de un estudio transversal, realizamos 12 encuestas 
con un muestreo independiente en cada una de ellas entre noviembre 
de 2004 y septiembre de 2011 en Lusaka. En cada encuesta, se solicitó 
a los cabezas de familia de 3600 hogares que indicaran el número de 
muertes en los últimos 12 meses y el número de huérfanos menores 
de 16 años en sus hogares y se investigaron los conocimientos, 
actitudes y prácticas de los cabezas de familia en relación con virus de 
la inmunodeficiencia humana (VIH).
Resultados El número de muertes registradas – por 100 personas al 
año – en cada encuesta varió de 0,92 (intervalo de confianza del 95%, 
IC: 0,78–1,09) en septiembre de 2011 a 1,94 (IC del 95%: 1,60–2,35) 
en marzo de 2007. Descubrimos que la mortalidad solo se redujo 
ligeramente cada año (razón del índice de mortalidad: 0,98; IC del 95%: 
0,95–1,00; P = 0,093). La proporción de hogares con huérfanos menores 
de 16 años disminuyó del 17% en 2004 al 7% en 2011. La proporción de 
los encuestados que nunca se había sometido a las pruebas del VIH, que 
tenía un conocimiento amplio sobre el VIH, que sabía dónde obtener 
tratamiento antirretroviral gratuito y que informó de que un miembro 
no embarazado del hogar recibía TARV aumentó gradualmente.
Conclusión La expansión de los servicios de TARV en Lusaka no estuvo 
asociada a una reducción en la mortalidad general. Si se pretende que la 
TARV tenga un efecto importante y duradero en el nivel de población de 
Lusaka, es posible que sea necesario reforzar la cobertura, la adherencia 
y la retención de los pacientes.
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